Last reviewed · How we verify

NCT05203874: CT-COARCT-PED

Contribution of Multimodal Imaging in Early Coarctation

Status unknown Last updated 1 February 2022
What this trial tests

trial in Aortic Coarctation in 800 participants. Status unknown.

Timeline
1 January 2022
Primary endpoint
1 December 2022
29 December 2022

Quick facts

Lead sponsorUniversity Hospital, Montpellier
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment800
Start date1 January 2022
Primary completion1 December 2022
Estimated completion29 December 2022
Sites1 location across France

Conditions studied

Sponsor

University Hospital, Montpellier

Who can join

Under 1, any sex, with Aortic Coarctation or Congenital Heart Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The CT-Coarct-PED study is a multicentred observational study aiming to describe the population of early coarctation during the last 10 years in South of France. The secondary objective is to assess the importance of cross-sectional imaging in the surgical management of aortic coarctation in the first year of life

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Aortic Coarctation

Currently open trials in the same condition.

Other University Hospital, Montpellier trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05203874.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing